Poolside is an AI-powered software development platform that provides tools for code autocompletion and other development tasks, primarily serving Global 2000 companies and public-sector agencies.

Memo Therapeutics is a late-stage biotech company that has raised CHF 25M in a Series C funding round to develop its antibody, AntiBKV, and advance its existing antibody pipeline.